From: Survival and prognostic factors for adrenocortical carcinoma: a single institution experience
Variable | Number | Percent |
---|---|---|
Gender | ||
Females | 42 | 58.3 |
Males | 30 | 41.7 |
Age | ||
<20 | 2 | 2.8 |
21–30 | 4 | 5.6 |
31–40 | 7 | 9.7 |
41–50 | 24 | 33.3 |
51–60 | 19 | 26.4 |
61–70 | 16 | 22.2 |
70+ | ||
Stage of disease | ||
I | 2 | 3.1 |
II | 31 | 48.4 |
III | 20 | 31.3 |
IV | 11 | 17.2 |
Tumour size | ||
<100 | 43 | 71.7 |
101+ | 17 | 28.3 |
Tumour weight | ||
<300 | 39 | 69.6 |
301+ | 17 | 30.4 |
Lymphatic metastasis | ||
Yes | 8 | 12.1 |
No | 58 | 87.9 |
Distant metastases | ||
Yes | 6 | 8.8 |
No | 62 | 91.2 |
Local infiltration | ||
Yes | 29 | 42.6 |
No | 39 | 57.4 |
Surgical approach | ||
Subcostal laparotomy | 48 | 66.7 |
Transdorsal lumbotomy sec.Young | 16 | 22.2 |
Median laparotomy | 1 | 1.4 |
Bilateral subcostal laparotomy | 3 | 4.2 |
Lumbotomy sec. Kifer | 3 | 4.2 |
Transrectal laparotomy | 1 | 1.4 |
Tumour localization | ||
Left side | 34 | 47.2 |
Right side | 37 | 51.4 |
Bilateral | 1 | 1.4 |
Type of operation | ||
Biopsy | 5 | 7.1 |
Tumour reduction | 3 | 4.3 |
Adrenalectomy | 50 | 71.4 |
Extended adrenalectomy | 12 | 17.1 |
Surgeons experience | ||
Specialist up to 10 years | 21 | 29.2 |
Specialist over 10 years | 51 | 70.8 |
Mitotane | ||
Yes | 30 | 63.8 |
No | 17 | 36.2 |
Hormonal activity | ||
Functional | 19 | 26.4 |
Afunctional | 53 | 73.6 |
Clinical presentation | ||
Asymptomatic | 28 | 38.9 |
Symptomatic | 44 | 61.1 |